LabGenomics Co. Ltd
LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.
Market Cap & Net Worth: LabGenomics Co. Ltd (084650)
LabGenomics Co. Ltd (KQ:084650) has a market capitalization of $8.59 Million (₩12.58 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24330 globally and #1392 in its home market, demonstrating a -1.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LabGenomics Co. Ltd's stock price ₩1386.00 by its total outstanding shares 9076740 (9.08 Million).
LabGenomics Co. Ltd Market Cap History: 2015 to 2026
LabGenomics Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $14.09 Million to $8.59 Million (-5.27% CAGR).
Index Memberships
LabGenomics Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #697 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #697 of 1384 |
Weight: LabGenomics Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LabGenomics Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LabGenomics Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
LabGenomics Co. Ltd's market cap is 0.00 times its annual revenue
0.00x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $14.09 Million | $23.59 Billion | $1.63 Billion | 0.00x | 0.01x |
| 2016 | $10.26 Million | $24.06 Billion | $723.51 Million | 0.00x | 0.01x |
| 2017 | $10.26 Million | $24.81 Billion | -$3.44 Billion | 0.00x | N/A |
| 2018 | $6.16 Million | $27.54 Billion | -$3.97 Billion | 0.00x | N/A |
| 2019 | $5.09 Million | $33.18 Billion | $962.42 Million | 0.00x | 0.01x |
| 2020 | $18.65 Million | $119.48 Billion | $42.77 Billion | 0.00x | 0.00x |
| 2021 | $24.98 Million | $202.41 Billion | $83.85 Billion | 0.00x | 0.00x |
| 2022 | $19.53 Million | $144.77 Billion | $48.40 Billion | 0.00x | 0.00x |
| 2023 | $23.90 Million | $71.08 Billion | -$4.67 Billion | 0.00x | N/A |
| 2024 | $15.44 Million | $85.90 Billion | -$23.80 Billion | 0.00x | N/A |
Competitor Companies of 084650 by Market Capitalization
Companies near LabGenomics Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to LabGenomics Co. Ltd by market ranking:
- Las Condes (SN:LASCONDES): Ranked #40485 globally with a market cap of $126.42K USD ( CL$127.04 Million CLP).
- Shifa International Hospitals Ltd (KAR:SHFA): Ranked #44147 globally with a market cap of $16.57K USD ( PKRs4.62 Million PKR).
- Bonzun AB (ST:BONZUN): Ranked #45272 globally with a market cap of $8.22K USD ( Skr92.23K SEK).
- Cannassure Therapeutics Ltd (TA:CSURE): Ranked #48747 globally with a market cap of $583.00 USD ( ILA217.46K ILA).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #40485 | Las Condes | SN:LASCONDES | $126.42K | CL$13650.00 |
| #44147 | Shifa International Hospitals Ltd | KAR:SHFA | $16.57K | PKRs474.18 |
| #45272 | Bonzun AB | ST:BONZUN | $8.22K | Skr9.50 |
| #48747 | Cannassure Therapeutics Ltd | TA:CSURE | $583.00 | ILA735.00 |
LabGenomics Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, LabGenomics Co. Ltd's market cap moved from $14.09 Million to $ 8.59 Million, with a yearly change of -5.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩8.59 Million | -23.47% |
| 2025 | ₩11.23 Million | -27.27% |
| 2024 | ₩15.44 Million | -35.41% |
| 2023 | ₩23.90 Million | +22.38% |
| 2022 | ₩19.53 Million | -21.83% |
| 2021 | ₩24.98 Million | +33.91% |
| 2020 | ₩18.65 Million | +266.28% |
| 2019 | ₩5.09 Million | -17.31% |
| 2018 | ₩6.16 Million | -40.00% |
| 2017 | ₩10.26 Million | 0.00% |
| 2016 | ₩10.26 Million | -27.15% |
| 2015 | ₩14.09 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of LabGenomics Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.59 Million USD |
| MoneyControl | $8.59 Million USD |
| MarketWatch | $8.59 Million USD |
| marketcap.company | $8.59 Million USD |
| Reuters | $8.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.